Chemotherapy is indicated in two situations for the treatment of breast cancer:
First line treatment is with an anthracycline or mitozantrone. Resistant tumours may respond to a taxol compound.
Gemcitabine in combination with paclitaxel, in cases of breast cancer who have relapsed following adjuvant/neo-adjuvant chemotherapy, is recommended as an option for the treatment of metastatic breast cancer only when docetaxel monotherapy or docetaxel plus capecitabine are also considered appropriate (1).
Last reviewed 01/2018